MX364440B - Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada. - Google Patents

Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.

Info

Publication number
MX364440B
MX364440B MX2015012057A MX2015012057A MX364440B MX 364440 B MX364440 B MX 364440B MX 2015012057 A MX2015012057 A MX 2015012057A MX 2015012057 A MX2015012057 A MX 2015012057A MX 364440 B MX364440 B MX 364440B
Authority
MX
Mexico
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
guar gum
Prior art date
Application number
MX2015012057A
Other languages
English (en)
Other versions
MX2015012057A (es
Inventor
Muldoon Brendan
Sweeney Gerarde
Karen Boyd Emma
Gerald Loughlin Ryan
Original Assignee
Warner Chilcott Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co Llc filed Critical Warner Chilcott Co Llc
Publication of MX2015012057A publication Critical patent/MX2015012057A/es
Publication of MX364440B publication Critical patent/MX364440B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma de dosis farmacéutica de gelatina blanda que incluye (a) una cubierta que incluye gelatina; y (b) un relleno que incluye al menos un ingrediente activo, uno o más polietilenglicoles, y una goma de guar modificada. La forma de dosis farmacéutica de gelatina blanda mantiene su integridad (dureza) de cubierta y viscosidad de relleno después del almacenamiento.
MX2015012057A 2013-03-15 2014-03-14 Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada. MX364440B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361794906P 2013-03-15 2013-03-15
PCT/US2014/027145 WO2014152269A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Publications (2)

Publication Number Publication Date
MX2015012057A MX2015012057A (es) 2016-05-05
MX364440B true MX364440B (es) 2019-04-26

Family

ID=50588879

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2015012057A MX364440B (es) 2013-03-15 2014-03-14 Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.
MX2019004554A MX2019004554A (es) 2013-03-15 2015-09-09 Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019004554A MX2019004554A (es) 2013-03-15 2015-09-09 Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.

Country Status (14)

Country Link
US (3) US9795569B2 (es)
EP (2) EP3187170A1 (es)
JP (3) JP6335270B2 (es)
KR (1) KR20150131070A (es)
CN (2) CN111374959A (es)
AU (2) AU2014239994B2 (es)
BR (1) BR112015022946A8 (es)
CA (1) CA2906633C (es)
ES (1) ES2619121T3 (es)
HK (1) HK1218622A1 (es)
IL (1) IL241377B (es)
MX (2) MX364440B (es)
RU (1) RU2676480C2 (es)
WO (1) WO2014152269A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014152269A1 (en) * 2013-03-15 2014-09-25 Warner Chilcott Company, Llc Pharmaceutical soft gelatin capsule dosage form with modified guar gum
AU2016238337B2 (en) * 2015-03-26 2020-08-13 Patheon Softgels Inc. Liquisoft capsules
JP2017214299A (ja) * 2016-05-30 2017-12-07 ライオン株式会社 半固形製剤及びその製造方法
IL302889A (en) * 2020-11-13 2023-07-01 Pfizer Gelatin capsules containing talazofrib
CN116531444B (zh) * 2023-07-06 2023-10-10 健码制药（广东）有限公司 镇咳清肺软胶囊及其制备工艺

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
IT1275816B1 (it) 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US5989535A (en) 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
IN188719B (es) * 1997-09-08 2002-11-02 Panacea Biotec Ltd
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US20040131670A1 (en) 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
FR2843304B1 (fr) * 2002-08-07 2005-12-16 Ricarimpex Extraits de sangsues pour stents
WO2004073375A2 (en) 2003-02-18 2004-09-02 Ranbaxy Laboratories Limited Podophyllotoxin derivatives as antitumor agents
KR100570450B1 (ko) * 2003-09-25 2006-04-12 한국유나이티드제약 주식회사 가용성 로바스타틴의 연질캡슐제 조성물 및 그의 제조방법
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US7067504B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
WO2005070949A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
WO2006138686A1 (en) 2005-06-16 2006-12-28 Warner Chilcott Company, Inc. Estrogen compositions for vaginal administration
CN101218245B (zh) 2005-07-12 2011-08-17 沃纳奇尔科特有限责任公司 炔雌醇的3-酯前药
EP1910402A2 (en) 2005-07-12 2008-04-16 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
US7468970B2 (en) 2005-10-24 2008-12-23 Honeywell International Inc. Routing of mobile agents in a network
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
WO2007056424A2 (en) 2005-11-07 2007-05-18 Penwest Pharmaceuticals, Co. Controlled-release emulsion compositions
WO2007066837A1 (en) 2005-12-06 2007-06-14 Lg Household & Health Care Ltd. Delivery system for tooth whitening component using in situ gelling
US20080305168A1 (en) 2006-02-10 2008-12-11 Kyo-Tae Moon In-Situ Melting and Gelling Tablet Composition For Oral Care
US20080090569A1 (en) 2006-10-13 2008-04-17 At&T Knowledge Ventures, L.P. Method and apparatus for performing signal processing in an ip multimedia subsystem network
US20080122993A1 (en) 2006-11-29 2008-05-29 Sanyo Electric Co., Ltd. Television image receiver
CN101588794A (zh) 2007-01-25 2009-11-25 万能药生物有限公司 调节释放药物组合物及其制备方法
WO2008122993A1 (en) 2007-04-09 2008-10-16 Panacea Biotec Limited Controlled release formulation of coated microparticles
WO2009119979A2 (ko) 2008-03-26 2009-10-01 크루셜텍(주) 광 포인팅장치 및 이를 갖는 휴대 전자기기
CN101474167A (zh) * 2009-01-23 2009-07-08 西安德天药业股份有限公司 雌二醇阴道用胶囊的制备方法
US20110003000A1 (en) 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
WO2014152269A1 (en) * 2013-03-15 2014-09-25 Warner Chilcott Company, Llc Pharmaceutical soft gelatin capsule dosage form with modified guar gum

Also Published As

Publication number Publication date
US20150044285A1 (en) 2015-02-12
CN105307634A (zh) 2016-02-03
HK1218622A1 (zh) 2017-03-03
US20180036252A1 (en) 2018-02-08
WO2014152269A1 (en) 2014-09-25
EP2950781A1 (en) 2015-12-09
BR112015022946A2 (pt) 2017-07-18
AU2014239994B2 (en) 2019-01-24
ES2619121T3 (es) 2017-06-23
JP2020147569A (ja) 2020-09-17
CN105307634B (zh) 2020-03-10
JP6704430B2 (ja) 2020-06-03
MX2015012057A (es) 2016-05-05
MX2019004554A (es) 2019-08-05
US9820946B2 (en) 2017-11-21
CA2906633A1 (en) 2014-09-25
US10744096B2 (en) 2020-08-18
BR112015022946A8 (pt) 2022-11-29
CN111374959A (zh) 2020-07-07
AU2019200116A1 (en) 2019-01-31
IL241377B (en) 2019-08-29
AU2014239994A1 (en) 2015-10-08
IL241377A0 (en) 2015-11-30
EP2950781B1 (en) 2016-12-21
RU2676480C2 (ru) 2018-12-29
US9795569B2 (en) 2017-10-24
US20140271838A1 (en) 2014-09-18
JP2016513684A (ja) 2016-05-16
KR20150131070A (ko) 2015-11-24
JP2018140998A (ja) 2018-09-13
RU2015137612A (ru) 2017-04-24
EP3187170A1 (en) 2017-07-05
NZ712280A (en) 2021-01-29
CA2906633C (en) 2021-11-30
JP6335270B2 (ja) 2018-05-30

Similar Documents

Publication Publication Date Title
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
MX2015011163A (es) Capsula entericas blandas que no contienen gelatina.
MX2019002575A (es) Microcapsulas biodegradables que contienen material de relleno.
PH12017502431A1 (en) Pharmaceutical formulations comprising tenofovir and emtrictabine
EP3344212A4 (en) MEDICAL PACK AND DOSAGE PLAN SYSTEM
GEP20217243B (en) Orodispersible dosage unit containing an estetrol component
MX2015008069A (es) Conjunto de envasado para dispositivos de administracion de farmacos.
PE20181095A1 (es) Envase blister
EP3247322A4 (en) Medication packaging and dose regimen system
EP3384891A4 (en) MEDICAMENT CARTET, DRUG DELIVERY AND MEDICAMENT PACKAGING DEVICE
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
MX2016003754A (es) Una composicion farmaceutica estable que contiene amlodipina y valsartan.
MX2015012075A (es) Forma de dosis farmaceutica de capsula de gelatina blanda.
MX2018001221A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
IN2013MU03370A (es)
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
IN2014MU00043A (es)
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form
GB2576446B (en) Shape memory alloy based drug delivery device
PH12014502170B1 (en) Drug composition and soft capsule drug sealing the drug composition
IN2013MU02015A (es)
MX2018001222A (es) Composicion farmaceutica con estabilidad de almacenamiento mejorada y metodo para prepararla.
WO2013144976A3 (en) Chewable soft gelatin capsule dosage form of mucolytic agents
GEP20196989B (en) Pharmaceutical composition comprising bisoprolol and perindoril
UY35324A (es) Composiciones farmacéuticas que contienen dexketoprofeno y tramadol

Legal Events

Date Code Title Description
FG Grant or registration